Hims & Hers launches into Canada as country prepare for generic GLP-1 weight loss drugs
Hims & Hers launched in Canada after announcing the company completed its all-cash acquisition of Canadian digital health provider “Livewell”. The deal comes just one month before generic semaglutide weight loss drugs come to market in the country. Brandon Gomez spoke exclusively with CEO Andrew Dudum about the deal and what it means for the […]
GLP-1 Receptor Agonist Use Linked to Chronic Cough Among Adults With Type 2 Diabetes
THURSDAY, Dec. 4, 2025 — For patients with type 2 diabetes, there is an association between glucagon-like peptide-1 receptor agonist (GLP-1 RA) use and chronic cough, according to a study published online Nov. 26 in JAMA Otolaryngology-Head &…
World Health Organization Recommends GLP-1 Drugs Like Ozempic For Obesity. Here’s What To Know
The World Health Organization conditionally recommended GLP-1 drugs for obesity. A physician breaks down what you need to know about this historic announcement.
Ozempic for pets: Everything you need to know
Okava Pharmaceuticals, a biopharmaceutical company, has launched a pilot study of a GLP-1 drug for cats with obesity
Could weight loss drugs be used to treat obese pets?
Experts say roughly six in 10 cats in the U.S. are carrying too much weight. A new clinical trial, “MEOW-1,” could change that, testing to see if GLP-1 weight loss drugs can be used on pets. Ash-har Quraishi reports.
Eli Lilly Cuts Zepbound Price to Widen Access for Obesity Drug
Eli Lilly said on Monday it has lowered the price of single-dose vials of its popular obesity drug Zepbound to make the treatment more affordable for U.S. patients, as… Reuters Health Information
STAT+: New data confirm Novo drug did not slow Alzheimer’s progression
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We’ve got a lot of biotech news to get to today. STAT is also launching a 10-part series called “American Science, Shattered” today. You can read the first few stories here. Continue […]
Knownwell Builds A New Model For Obesity Care
Knownwell delivers weight-inclusive primary care and metabolic health treatment as demand for GLP-1 weight-loss drugs grows and telemedicine rules tighten.
Weight loss drugs for cats? Company launches clinical trial of GLP-1 implants in cats – ABC News
Weight loss drugs for cats? Company launches clinical trial of GLP-1 implants in cats ABC News Could Weight Loss Drugs Turn Fat Cats Into Svelte Ozempets? The New York Times Ozempets: will weight-loss jabs for cats and dogs make them miserable? The Guardian ‘MEOW-1’: Could your pet be on weight loss drugs? Company launches clinical trial KOMO Ozempic for […]
GLP‐1 Receptor Agonist Medications for Obesity and Type 2 Diabetes Treatment: A Rapid Review of Changes in Eating Behaviors and Eating Disorder Risk
ABSTRACT This rapid review aimed to evaluate the effects of GLP-1 RAs on eating behaviors and eating disorder risk. Databases were searched to January 2025 to identify studies evaluating GLP-1 RA treatment for adolescents or adults with obesity or Type 2 diabetes. Eligible studies reported adverse events, changes in eating disorder risk, or eating behaviors […]